Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-31

FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for tenofovir disoproxil fumarate filed by Macleods Pharmaceuticals Limited under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

SUPPL AP for TENOFOVIR DISOPROXIL FUMARATE (TENOFOVIR DISOPROXIL FUMARATE)